FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

2152111000001104: Carbamazepine 400mg modified-release tablets (Kent Pharma (UK) Ltd) 56 tablet 4 x 14 tablets (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1872341000001112 Carbamazepine 400mg modified-release tablets (Kent Pharma (UK) Ltd) 56 tablet 4 x 14 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1872351000001110 Carbamazepine 400mg modified-release tablets (Kent Pharma (UK) Ltd) 56 tablet 4 x 14 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Carbamazepine 400mg modified-release tablets (Kent Pharma (UK) Ltd) 56 tablet 4 x 14 tablets VMP prescribing status (attribute) Caution - AMP level prescribing advised true Inferred relationship Existential restriction modifier
Carbamazepine 400mg modified-release tablets (Kent Pharma (UK) Ltd) 56 tablet 4 x 14 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Carbamazepine 400mg modified-release tablets (Kent Pharma (UK) Ltd) 56 tablet 4 x 14 tablets Is a Carbamazepine 400mg modified-release tablets 56 tablet true Inferred relationship Existential restriction modifier
Carbamazepine 400mg modified-release tablets (Kent Pharma (UK) Ltd) 56 tablet 4 x 14 tablets Is pack of Carbamazepine 400mg modified-release tablets (Kent Pharma (UK) Ltd) false Inferred relationship Existential restriction modifier
Carbamazepine 400mg modified-release tablets (Kent Pharma (UK) Ltd) 56 tablet 4 x 14 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Carbamazepine 400mg modified-release tablets (Kent Pharma (UK) Ltd) 56 tablet 4 x 14 tablets Has active ingredient Carbazepine antiepileptic false Inferred relationship Existential restriction modifier
Carbamazepine 400mg modified-release tablets (Kent Pharma (UK) Ltd) 56 tablet 4 x 14 tablets Has active ingredient Carbamazepine false Inferred relationship Existential restriction modifier
Carbamazepine 400mg modified-release tablets (Kent Pharma (UK) Ltd) 56 tablet 4 x 14 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Carbamazepine 400mg modified-release tablets (Kent Pharma (UK) Ltd) 56 tablet 4 x 14 tablets Discontinued indicator Discontinued AMPP(qualifier value) false Inferred relationship Existential restriction modifier
Carbamazepine 400mg modified-release tablets (Kent Pharma (UK) Ltd) 56 tablet 4 x 14 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Carbamazepine 400mg modified-release tablets (Kent Pharma (UK) Ltd) 56 tablet 4 x 14 tablets VMP prescribing status (attribute) VMP valid as a prescribable product false Inferred relationship Existential restriction modifier
Carbamazepine 400mg modified-release tablets (Kent Pharma (UK) Ltd) 56 tablet 4 x 14 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Carbamazepine 400mg modified-release tablets (Kent Pharma (UK) Ltd) 56 tablet 4 x 14 tablets Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Carbamazepine 400mg modified-release tablets (Kent Pharma (UK) Ltd) 56 tablet 4 x 14 tablets Has AMP Carbamazepine 400mg modified-release tablets (Kent Pharma (UK) Ltd) true Inferred relationship Existential restriction modifier
Carbamazepine 400mg modified-release tablets (Kent Pharma (UK) Ltd) 56 tablet 4 x 14 tablets Has specific active ingredient Carbamazepine true Inferred relationship Existential restriction modifier
Carbamazepine 400mg modified-release tablets (Kent Pharma (UK) Ltd) 56 tablet 4 x 14 tablets Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Carbamazepine 400mg modified-release tablets (Kent Pharma (UK) Ltd) 56 tablet 4 x 14 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Carbamazepine 400mg modified-release tablets (Kent Pharma (UK) Ltd) 56 tablet 4 x 14 tablets Discontinued indicator Re-marketed false Inferred relationship Existential restriction modifier
Carbamazepine 400mg modified-release tablets (Kent Pharma (UK) Ltd) 56 tablet 4 x 14 tablets VMP prescribing status (attribute) VMP not recommended to prescribe - brands not bioequivalent false Inferred relationship Existential restriction modifier
Carbamazepine 400mg modified-release tablets (Kent Pharma (UK) Ltd) 56 tablet 4 x 14 tablets Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start